Twist Bioscience Corporation
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-35.1M | $-44.0M | $-30.5M | $-27.1M | $20.4M | $-39.3M | $-31.6M | $-34.7M |
| Depreciation & Amortization | $6.8M | $6.4M | $6.2M | $6.0M | $6.1M | $6.4M | $6.4M | $6.7M |
| Depreciation | $6.5M | $6.1M | $5.9M | $5.8M | $5.8M | $6.1M | $6.1M | $6.4M |
| Amortization | $300.0K | $300.0K | $300.0K | $200.0K | $300.0K | $300.0K | $300.0K | $200.0K |
| Stock-Based Compensation | $18.2M | $18.9M | $13.3M | $16.1M | $16.1M | $20.3M | $12.0M | $12.3M |
| Net Cash from Operating Activities | $1.1M | $-17.6M | $-24.8M | $-11.8M | $-1.4M | $-13.0M | $-21.4M | $-15.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $9.8M | $7.9M | $10.0M | $12.4M | $9.2M | $4.1M | $2.3M | $2.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-10.2M | $-12.7M | $-9.9M | $-12.4M | $-9.4M | $-1.4M | $-1.5M | $-1.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.8M | $4.1M | $298.0K | $5.6M | $1.8M | $3.2M | $17.9M | $3.6M |
| Net Change in Cash | $-5.3M | $-26.1M | $-34.4M | $-18.5M | $-9.0M | $-11.1M | $-5.1M | $-12.9M |
| Free Cash Flow | $-8.6M | $-25.4M | $-34.8M | $-24.2M | $-10.6M | $-17.1M | $-23.7M | $-17.3M |